Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FTI Consulting to Release Fourth Quarter and Full Year 2024 Results and Host Conference Call
-
Cytokinetics Announces Recipients of Its Seventh Annual Communications Grant Program
-
Watsco Schedules Conference Call to Review 2024 Fourth Quarter Performance and Annual Results
-
Prodege to Deliver Over $250 Million in Revenue to Mobile Gaming Clients in 2025 Through Rewarded User Acquisition
-
Kelly Announces Fourth-Quarter and Full-Year 2024 Conference Call
-
NANO Nuclear Energy to Work with Thermal Engineering International to Fabricate Primary and Secondary Heat Exchangers for its Portable ODIN Microreactor
-
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™
-
Spider Vision Sensors Collaborates with Suntek Global to Apply for First Blue UAS Certification of IQ Nano Drone Sensor for US Defense
-
Quipt Home Medical Corp. to Announce Fiscal First Quarter 2025 Financial Results on February 10, 2025
-
Easy Metrics Launches Profit Management Solution to Enhance 3PL Operating Margins up to 3%
-
Curium Expands European Supply of Iodine-131 Diagnostic Capsules with New Partnership Agreement with Izotop
-
-
Form 8.5 (EPT/RI) - Dowlais Group Plc
-
Yummiland™ Brings Back Num Noms™ in New Body Scents for Kid-Friendly, Cosmetic Fun
-
National Tax Practice Institute® (NTPI®) Education Program Returns to 2025 Tax Summit This July
-
Velocity Clinical Research Partners with Verified Clinical Trials to combat double enrollment problem in clinical trials
-
Northfield Capital Announces Updates From Cornerstone Investment Juno Corp. and Forward Share Split
-
Rogers Communications Declares 50 Cents per Share Quarterly Dividend
-
Rogers Communications Reports Fourth Quarter 2024 Results; Announces 2025 Financial Guidance
-
SpringWorks Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 20, 2025
-
Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call
-
Asante Accelerates Bibiani Ramp-Up
-
Matador Acquires 3.38 Bitcoin for CAD$500,000, Bringing Its Total Bitcoin (and Bitcoin Equivalent) Holdings to 64.69
-
Dianthus Therapeutics to Webcast Presentations at Two Investor Conferences
-
Halcones Precious Metals Closes Transaction to Acquire the Polaris Project
-
Abcourt Intersects 3.5 g/t Gold Over 27.5 Metres Directly Below Cartwright Stripping on Its Flordin Property in the Lebel-sur-Quévillon Area
-
OneWater Marine Inc. Announces Fiscal First Quarter Results
-
Jamieson Wellness Inc. Announces Normal Course Issuer Bid
-
NexGold Commences Next Phase of Diamond Drilling at the Goliath Gold Complex
-
Brookfield Infrastructure Reports Strong 2024 Year-End Results & Declares 16th Consecutive Distribution Increase
-
Sandy Spring Bancorp Declares Quarterly Dividend
-
EyePoint to Present at Guggenheim SMID Cap Biotech Conference
-
Lantronix to Report Fiscal 2025 Second Quarter Results on Feb. 6, 2025
-
Kymera Therapeutics to Participate in Upcoming February Investor Conferences
-
Tango Therapeutics to Present at the Guggenheim SMID Cap Biotechnology Conference
-
Aduro Clean Technologies Files New Patent Application on Novel Process Design
-
Brookfield Infrastructure Reports Strong 2024 Year-End Results & Declares 16th Consecutive Distribution Increase
-
Hangcha Forklift Canada Secures Major Contracts Through Dealer-Led Partnerships
-
Brightstar Capital Partners Acquires WW Williams, a Nationwide Provider of Mechanical Repair Services and Products
-
Talisker Completes Golden Hornet Option Agreement
-
Annual Anaqua Analysis of USPTO Data Finds Strong Increase in Patent Grant Activity
-
Curonix leads the PNS market with expanded MR Labeling for 3T Full-Body MRI Scans for its Freedom® Peripheral Nerve Stimulator (PNS) System
-
Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference
-
Malibu Boats, Inc. Announces Second Quarter Fiscal 2025 Results
-
Beam Global Expands European Sales Network with Three New Distribution Partners
-
Connectone Bancorp, Inc. Reports Fourth Quarter and Full-Year 2024 Results; Declares Common and Preferred Dividends
-
Kirby Corporation Announces 2024 Fourth Quarter and Full Year Results
-
Vigil Neuroscience to Present at Guggenheim Securities SMID Cap Biotech Conference
-
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
-
Allegro MicroSystems Reports Third Quarter 2025 Results
